Metrics as of 10/17/2026, 08:40 AM (Berlin time), refresh in progress.
Evotec Stock
Evotec SE
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Germany
- CEO
- Christian Wojczewski
- Employees
- 4,461
- Market cap
- €456 M
- IPO
- 12/11/1999
Evotec SE functions as a global collaborator, aiding the pharmaceutical and biotechnology industries in the identification and progression of novel drug candidates. The firm is actively engaged in advancing medicinal products designed to treat a diverse array of health challenges, including diabetes and its related…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
Evotec stock: price history
1D
+1.6%
1W
-7.2%
1M
-8.5%
6M
-54.4%
YTD
-52.8%
1Y
-62.6%
2Y
-52.5%
5Y
-93.8%
10Y
-49.0%
Next earnings date
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~86% stronger price swings than usual
Ask the agents about Evotec
Analyst assessment of Evotec
0
STRONG BUY
3
BUY
2
HOLD
0
SELL
0
STRONG SELL
5
TOTAL · Buy
As of: 30/08/2023
Evotec stock metrics
P/E
-2.32
P/B
0.69
EV/EBITDA
-20.93
RETURN ON EQUITY
-7.0%
NET MARGIN
-32.5%
DEBT/EQUITY
0.71
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
76.3%
FLOAT SHARES
135,490,460
AVG. DAILY VOLUME (30D)
1,179,497
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Evotec stock
What does Evotec do?
Evotec SE is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in Germany.
The CEO is Christian Wojczewski, the company employs around 4,461 people.
The IPO was on 12/11/1999; the stock trades on XETRA under the ticker EVT.DE.
What do analysts say about Evotec stock?
5 analysts rate the stock, the consensus is Buy (as of 30/08/2023).
This is an external assessment, not a statement by Market Jury.
When does Evotec report next?
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly 86% stronger than usual.
Does Evotec pay a dividend?
No, Evotec currently does not pay a dividend.
Which stocks are comparable to Evotec?
Comparable stocks include Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Sandoz Group, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.
How can I get Evotec stock analyzed?
Clicking "Analyze stock" lets five strategies assess Evotec against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.